Repligen Corporation to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the 13th Annual BIO CEO and Investor Conference on Monday, February 14th, 2011 at 11:30 a.m. EST at the Waldorf-Astoria Hotel, 301 Park Avenue, New York, NY. A live audio webcast of the presentation will be available via Repligen’s website at www.repligen.com and will be archived for 30 days following the presentation.

MORE ON THIS TOPIC